334 related articles for article (PubMed ID: 28333145)
1. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4
He K; Liu P; Xu LX
Cell Death Dis; 2017 Mar; 8(3):e2703. PubMed ID: 28333145
[TBL] [Abstract][Full Text] [Related]
2. IFNγ at the early stage induced after cryo-thermal therapy maintains CD4
Wang J; Lou Y; Wang S; Zhang Z; You J; Zhu Y; Yao Y; Hao Y; Liu P; Xu LX
Front Immunol; 2024; 15():1345046. PubMed ID: 38827732
[TBL] [Abstract][Full Text] [Related]
3. A role of eosinophils in mediating the anti-tumour effect of cryo-thermal treatment.
Jia S; Li W; Liu P; Xu LX
Sci Rep; 2019 Sep; 9(1):13214. PubMed ID: 31519961
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
5. Th1-Dominant CD4
Peng P; Lou Y; Wang J; Wang S; Liu P; Xu LX
Front Immunol; 2022; 13():944115. PubMed ID: 35874660
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
Tsukamoto H; Nishikata R; Senju S; Nishimura Y
Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
[TBL] [Abstract][Full Text] [Related]
7. Neoantigen-specific CD4
Peng P; Hu H; Liu P; Xu LX
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32938627
[TBL] [Abstract][Full Text] [Related]
8. Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity.
Kudo-Saito C; Fuwa T; Kawakami Y
Eur J Cancer; 2016 Jul; 62():54-61. PubMed ID: 27208904
[TBL] [Abstract][Full Text] [Related]
9. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
Li T; Harada M; Tamada K; Abe K; Nomoto K
Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
[TBL] [Abstract][Full Text] [Related]
10. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
[TBL] [Abstract][Full Text] [Related]
11. Downregulated TNF-α Levels after Cryo-Thermal Therapy Drive Tregs Fragility to Promote Long-Term Antitumor Immunity.
Lou Y; Wang J; Peng P; Wang S; Liu P; Xu LX
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576115
[TBL] [Abstract][Full Text] [Related]
12. Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity.
He K; Jia S; Lou Y; Liu P; Xu LX
Cell Death Dis; 2019 Mar; 10(3):216. PubMed ID: 30833570
[TBL] [Abstract][Full Text] [Related]
13. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
14. Cryo-thermal therapy inducing MI macrophage polarization created CXCL10 and IL-6-rich pro-inflammatory environment for CD4
Liu P; Jia S; Lou Y; He K; Xu LX
Int J Hyperthermia; 2019; 36(1):408-420. PubMed ID: 30892102
[TBL] [Abstract][Full Text] [Related]
15. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
[TBL] [Abstract][Full Text] [Related]
17. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
[TBL] [Abstract][Full Text] [Related]
18. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
[TBL] [Abstract][Full Text] [Related]
19. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.
Steitz J; Brück J; Lenz J; Knop J; Tüting T
Cancer Res; 2001 Dec; 61(24):8643-6. PubMed ID: 11751377
[TBL] [Abstract][Full Text] [Related]
20. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
